symp1

0

C. Masters (Australia): Mechanisms of degeneration in Alzheimer’s disease – towards a rational therapy.

G. Schettini (Italy): New insight in amylo´d precursor protein processing. Identification of molecular targets for pharmacological interventions in Alzheimer’s disease.

R. Nitsch (Germany): Prevention of brain amylo´d formation in vivo.

M. Di Luca (Italy): Alpha and beta secretase activity in platelets of Alzheimer’s disease patients.

J. Buxbaum (U.S.A.): Ab as a therapeutic target in Alzheimer’s disease.

G. Carlesimo (Italy): Implicit memory processes in Alzheimer’s disease.